These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16040258)

  • 1. Characterization of compound mechanisms and secondary activities by BioMAP analysis.
    Berg EL; Kunkel EJ; Hytopoulos E; Plavec I
    J Pharmacol Toxicol Methods; 2006; 53(1):67-74. PubMed ID: 16040258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative biology approach for analysis of drug action in models of human vascular inflammation.
    Kunkel EJ; Dea M; Ebens A; Hytopoulos E; Melrose J; Nguyen D; Ota KS; Plavec I; Wang Y; Watson SR; Butcher EC; Berg EL
    FASEB J; 2004 Aug; 18(11):1279-81. PubMed ID: 15208272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical target and pathway toxicity mechanisms defined in primary human cell systems.
    Berg EL; Yang J; Melrose J; Nguyen D; Privat S; Rosler E; Kunkel EJ; Ekins S
    J Pharmacol Toxicol Methods; 2010; 61(1):3-15. PubMed ID: 19879948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models.
    Kunkel EJ; Plavec I; Nguyen D; Melrose J; Rosler ES; Kao LT; Wang Y; Hytopoulos E; Bishop AC; Bateman R; Shokat KM; Butcher EC; Berg EL
    Assay Drug Dev Technol; 2004 Aug; 2(4):431-41. PubMed ID: 15357924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems.
    Houck KA; Dix DJ; Judson RS; Kavlock RJ; Yang J; Berg EL
    J Biomol Screen; 2009 Oct; 14(9):1054-66. PubMed ID: 19773588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
    Fukushima H; Hirano T; Oka K
    Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell network profiling (SCNP): mapping drug and target interactions.
    Covey TM; Putta S; Cesano A
    Assay Drug Dev Technol; 2010 Jun; 8(3):321-43. PubMed ID: 20158439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model.
    Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V
    Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies.
    Dhir V; Fort M; Mahmood A; Higbee R; Warren W; Narayanan P; Wittman V
    J Immunotoxicol; 2012; 9(1):34-42. PubMed ID: 22074378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activity.
    Jiang W; Kou J; Yuan S; Sun L; Yu B
    J Biomol Screen; 2011 Mar; 16(3):295-302. PubMed ID: 21310849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury.
    Schuh K; Pahl A
    Biochem Pharmacol; 2009 Jun; 77(12):1827-34. PubMed ID: 19428337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining RNA interference and kinase inhibitors against cell signalling components involved in cancer.
    O'Grady M; Raha D; Hanson BJ; Bunting M; Hanson GT
    BMC Cancer; 2005 Oct; 5():125. PubMed ID: 16202132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB-mediated anti-inflammatory activity of the sesquiterpene lactone 7-hydroxyfrullanolide.
    Fonseca LC; Dadarkar SS; Lobo AS; Mishra PB; Thakkar AD; Chandrababu S; Padigaru M
    Eur J Pharmacol; 2011 Apr; 657(1-3):41-50. PubMed ID: 21296061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.
    Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ
    Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.